코오롱티슈진
1 known investors
Kolon TissueGene is a clinical-stage biopharmaceutical company developing cell therapies for degenerative musculoskeletal diseases. Its lead investigational drug, TG-C, is in Phase III trials as a treatment for knee osteoarthritis aimed at reducing pain, improving function, and slowing disease progression.
Investors · 1
Frequently asked questions
- What does 코오롱티슈진 do?
- Kolon TissueGene is a clinical-stage biopharmaceutical company developing cell therapies for degenerative musculoskeletal diseases. Its lead investigational drug, TG-C, is in Phase III trials as a treatment for knee osteoarthritis aimed at reducing pain, improving function, and slowing disease progression.
- Who are 코오롱티슈진's investors?
- 코오롱티슈진's investors include Kolon Investment, Inc..